Outstanding talk at #ASTRO2023 by @lauren_henke on advancing online CT guided adaptive radiotherapy, including testing its feasibility on C-arm linacs! @APrice_BeamOn @UHhospitals @WashURadOnc @JoshuaSchiffMD
Pamela Samson, MD retweeted
Great group at #SNOSTORM2023 sharing knowledge & learning how best to deliver #cardiac #radioablation to patients all around the world! Thanks for joining us in St Louis!
@stopstormEU #epeeps
Pamela Samson, MD retweeted
Registration is NOW OPEN for the SNOSTORM2023 conference on Sep 28-29, 2023. Hear from leaders in the field about treating ventricular tachycardia with noninvasive cardiac radioablation!
✅ Schedule & Registration: bit.ly/43D0RLI
#EPeeps #radonc
Pamela Samson, MD retweeted
"Sorry I think I have to take this unscheduled call from an anonymous number because if I miss it I think they will automatically deny payment for my patient's radiation. Five minutes. It's a US thing."
Pamela Samson, MD retweeted
🫀⚡️SAVE THE DATE! SNORAD & STOPSTORM are teaming up again for a great SNOSTORM conference on cardiac radiotherapy Sep 28-29 in St. Louis!
#epeeps #CRAforVT #radiateVT #SNOSTORM
@DoctorPhillEP @SBRT_CR @joostverhoeff @gdhugo @samsonpp @WashUCardiology @WUSTLmed @WashURadOnc
Pamela Samson, MD retweeted
Published today: ascopubs.org/doi/pdfdirect/1…
🧵2/ Metastasis-directed Tx to the 🫁 has limited trial evidence (surgery or SABR). Whilst convenient, popular during #COVID19, there is reluctance for single fraction fraction 🥊 SABR for perceived toxicity. @TROGfightcancer SAFRON II randomised n=90 with 133 🫁 mets to 1 vs 4fx SABR
Pamela Samson, MD retweeted
Proud of @JoshuaSchiffMD for not only knocking it out of park (honestly his baseline) presenting our in silico work evaluating #adaptiveSBRT for ultra-central thorax NSCLC but also having already made this into a @VarianMedSys funded, Ph I clinical trial (NCT05785845)! #ESTRO23 – at Vienna, Austria
Pamela Samson, MD retweeted
Does Pseudoprogression occur after spine met SBRT?
Yes, 16% of time after SBRT
· Transient ↑ signal abnl centered @ treated lesion followed by signal improvement on FU MR imaging not attributable to systemic therapy
doi.org/10.1259/bjr.20220266



















